Quadrant Capital Group LLC Beyond Spring Inc. Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$1.68 - $5.01 $940 - $2,805	-560 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$4.02 - $16.84 $7,625 - $31,945	-1,897 Reduced 77.21%	560 $3,000
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $12,482 - $42,205	1,348 Added 121.55%	2,457 $39,000
Q2 2021 Aug 09, 2021	BUY	$9.37 - $12.12 $10,016 - $12,956	1,069 Added 2672.5%	1,109 $12,000
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $408 - $692	40 New	40 $0

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.2M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.